Low ALT was a significant predictor of mortality even when controlled for other comorbidities such as age, gender, BMI, hypertension, diabetes mellitus, dementia, stroke, and pulmonary disease, with an OR = 1.88 (p < 0.01) in a logistic regression and a propensity score-matched cohort. This evidence concerns the gene GPT and Hypertension.